Evaluation of lipopolymer as therapeutic siRNA delivery agents in non-malignant and malignant primary cells.

被引:0
|
作者
Ansari, Aysha
Kucharski, Cezary
Mohseni, Mahsa
Sundaram, Daniel N. M.
Brandwein, Joseph M.
Jiang, Xiaoyan
Uludag, Hasan
机构
[1] Univ Alberta, Edmonton, AB, Canada
[2] British Columbia Canc Agcy, Vancouver, BC, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15189
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells
    Hillary E. Mulvey
    Audrey Chang
    Jason Adler
    Michael Del Tatto
    Kimberly Perez
    Peter J. Quesenberry
    Devasis Chatterjee
    BMC Cancer, 15
  • [32] SCANNING ELECTRON-MICROSCOPY OF EXFOLIATED MALIGNANT AND NON-MALIGNANT HUMAN UROTHELIAL CELLS
    CROFT, WA
    NELSON, CE
    NILSSON, T
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1979, 13 (01): : 49 - 57
  • [33] Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells
    Mulvey, Hillary E.
    Chang, Audrey
    Adler, Jason
    Del Tatto, Michael
    Perez, Kimberly
    Quesenberry, Peter J.
    Chatterjee, Devasis
    BMC CANCER, 2015, 15
  • [34] A non-malignant tumoral presentation of a rare primary-immunodeficiency
    Baleydier, F.
    Schappi-Tempia, M.
    Ranza, E.
    Rougemont, A. L.
    Merlini, L.
    Hofer, M.
    Posfay-Barbe, C.
    Ansari, M.
    Blanchard-Rohner, G.
    SWISS MEDICAL WEEKLY, 2017, 147 : 55S - 55S
  • [35] COMPARISON BETWEEN MEMBRANES OF MALIGNANT AND OF NON-MALIGNANT RAT COLONIC EPITHELIAL-CELLS
    BARKLA, DH
    TUTTON, PJM
    JOURNAL OF CELL BIOLOGY, 1976, 70 (02): : A63 - A63
  • [36] The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay
    C. Kelaidi
    V. Tzotzola
    S. Polychronopoulou
    Familial Cancer, 2021, 20 : 363 - 380
  • [37] Modulation of malignant and non-malignant primary human colonocyte differentiation by short chain fatty acids
    Emenaker, NJ
    Rashid, Z
    Basson, MD
    FASEB JOURNAL, 1997, 11 (03): : 3281 - 3281
  • [38] The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay
    Kelaidi, C.
    Tzotzola, V
    Polychronopoulou, S.
    FAMILIAL CANCER, 2021, 20 (04) : 363 - 380
  • [39] Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells
    Webber, MM
    Bello, D
    Kleinman, HK
    Hoffman, MP
    CARCINOGENESIS, 1997, 18 (06) : 1225 - 1231
  • [40] Hydroxyurea induces a senescent, non-malignant, immunogenic state in neuroblastoma cells - a new therapeutic strategy?
    Taschner-Mandl, S.
    Kowalska, A.
    Binder, H.
    Rieder, D.
    Trajanoski, Z.
    Khan, J.
    Speleman, F.
    Ambros, I
    Ambros, P.
    KLINISCHE PADIATRIE, 2010, 222 (03): : 224 - 224